Cargando…

Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children. Following earlier reports on an increase in the prevalence of childhood obesity, NAFLD is now becoming increasingly common in children. Although no definitive cure exists, early management, early diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamari, Negin, Moradinazar, Mehdi, Qasemi, Mahmoud, Khosravy, Tina, Samadi, Mehnoosh, Abdolahzad, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084988/
https://www.ncbi.nlm.nih.gov/pubmed/37051346
http://dx.doi.org/10.1002/fsn3.3218
_version_ 1785021840409755648
author Kamari, Negin
Moradinazar, Mehdi
Qasemi, Mahmoud
Khosravy, Tina
Samadi, Mehnoosh
Abdolahzad, Hadi
author_facet Kamari, Negin
Moradinazar, Mehdi
Qasemi, Mahmoud
Khosravy, Tina
Samadi, Mehnoosh
Abdolahzad, Hadi
author_sort Kamari, Negin
collection PubMed
description Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children. Following earlier reports on an increase in the prevalence of childhood obesity, NAFLD is now becoming increasingly common in children. Although no definitive cure exists, early management, early diagnosis, and treatment can reduce its complications. This study aims to determine the effectiveness of the combination of ginger and an anti‐inflammatory diet (AID) in children with obesity on fatty liver management. This randomized clinical trial was conducted on 160 children with obesity aged 8–11 years, with a mean (SD) weight of 65.01 (9.67) kg, mean (SD) height of 139.87 (7.37) cm, and mean (SD) body mass index of 33.40 (5.59) kg/m(2). The study duration was 12 weeks. Children were divided into four groups: ginger (G), AID, ginger plus an AID (GPA), and control. Ginger capsules comprised 1000 mg of ginger, whereas the AID comprised fruits and vegetables, fish, turkey, and chicken (without skin) with lean meat, omega‐3 sources, nuts, legumes, probiotic products, and elimination of inflammatory food. Following the intervention, serum fasting blood sugar and high‐sensitivity C‐reactive protein levels were significantly decreased in the AID (p = .006 and .002, respectively), G (p = .04 and <.001, respectively), and GPA (p <.001 in both cases, respectively) groups. Further, in the G and GPA groups, there was a significant decrease in body mass index (p = .04 in both cases, respectively), waist circumference (p = .009 and .003, respectively), waist‐to‐height ratio (p = .02 and .005, respectively), alanine aminotransferase (p = .004 and <.001, respectively), total cholesterol (p = .0002 and .0001, respectively) and low‐density lipoprotein‐cholesterol (p < .001 and <.001, respectively). Eventually, serum aspartate aminotransferase was decreased (p < .001) and high‐density lipoprotein‐cholesterol (p = .03) was increased significantly in the GPA group. As a main finding of this study, hepatic steatosis significantly decreased in the G and GPA groups. Ginger supplementation can effectively improve NAFLD in children, and its effectiveness was further increased when combined with an AID.
format Online
Article
Text
id pubmed-10084988
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100849882023-04-11 Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial Kamari, Negin Moradinazar, Mehdi Qasemi, Mahmoud Khosravy, Tina Samadi, Mehnoosh Abdolahzad, Hadi Food Sci Nutr Original Articles Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children. Following earlier reports on an increase in the prevalence of childhood obesity, NAFLD is now becoming increasingly common in children. Although no definitive cure exists, early management, early diagnosis, and treatment can reduce its complications. This study aims to determine the effectiveness of the combination of ginger and an anti‐inflammatory diet (AID) in children with obesity on fatty liver management. This randomized clinical trial was conducted on 160 children with obesity aged 8–11 years, with a mean (SD) weight of 65.01 (9.67) kg, mean (SD) height of 139.87 (7.37) cm, and mean (SD) body mass index of 33.40 (5.59) kg/m(2). The study duration was 12 weeks. Children were divided into four groups: ginger (G), AID, ginger plus an AID (GPA), and control. Ginger capsules comprised 1000 mg of ginger, whereas the AID comprised fruits and vegetables, fish, turkey, and chicken (without skin) with lean meat, omega‐3 sources, nuts, legumes, probiotic products, and elimination of inflammatory food. Following the intervention, serum fasting blood sugar and high‐sensitivity C‐reactive protein levels were significantly decreased in the AID (p = .006 and .002, respectively), G (p = .04 and <.001, respectively), and GPA (p <.001 in both cases, respectively) groups. Further, in the G and GPA groups, there was a significant decrease in body mass index (p = .04 in both cases, respectively), waist circumference (p = .009 and .003, respectively), waist‐to‐height ratio (p = .02 and .005, respectively), alanine aminotransferase (p = .004 and <.001, respectively), total cholesterol (p = .0002 and .0001, respectively) and low‐density lipoprotein‐cholesterol (p < .001 and <.001, respectively). Eventually, serum aspartate aminotransferase was decreased (p < .001) and high‐density lipoprotein‐cholesterol (p = .03) was increased significantly in the GPA group. As a main finding of this study, hepatic steatosis significantly decreased in the G and GPA groups. Ginger supplementation can effectively improve NAFLD in children, and its effectiveness was further increased when combined with an AID. John Wiley and Sons Inc. 2023-01-24 /pmc/articles/PMC10084988/ /pubmed/37051346 http://dx.doi.org/10.1002/fsn3.3218 Text en © 2023 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Kamari, Negin
Moradinazar, Mehdi
Qasemi, Mahmoud
Khosravy, Tina
Samadi, Mehnoosh
Abdolahzad, Hadi
Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title_full Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title_fullStr Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title_full_unstemmed Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title_short Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
title_sort combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: a randomized clinical trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084988/
https://www.ncbi.nlm.nih.gov/pubmed/37051346
http://dx.doi.org/10.1002/fsn3.3218
work_keys_str_mv AT kamarinegin combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial
AT moradinazarmehdi combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial
AT qasemimahmoud combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial
AT khosravytina combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial
AT samadimehnoosh combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial
AT abdolahzadhadi combinationoftheeffectofgingerandantiinflammatorydietonchildrenwithobesitywithnonalcoholicfattyliverdiseasearandomizedclinicaltrial